These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8671804)

  • 1. Genetic pattern in diabetic nephropathy.
    Tarnow L
    Nephrol Dial Transplant; 1996 Mar; 11(3):410-2. PubMed ID: 8671804
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetics of diabetes and its complications.
    Rich SS
    J Am Soc Nephrol; 2006 Feb; 17(2):353-60. PubMed ID: 16394110
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene polymorphism of the renin-angiotensin system and progression of diabetic nephropathy.
    Orisio S
    J Nephrol; 1999; 12(1):9-17. PubMed ID: 10202997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic factors with significance in pathogenesis of diabetic nephropathy--the role of polymorphism of renin-angiotensin system genes].
    Grzeszczak W
    Przegl Lek; 2000; 57 Suppl 3():19-24. PubMed ID: 11293230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary factors in the development of diabetic renal disease.
    Marre M; Hadjadj S; Bouhanick B
    Diabetes Metab; 2000 Jul; 26 Suppl 4():30-6. PubMed ID: 10922971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group.
    Schmidt S; Giessel R; Bergis KH; Strojek K; Grzeszczak W; Ganten D; Ritz E
    Nephrol Dial Transplant; 1996 Sep; 11(9):1755-61. PubMed ID: 8918618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients.
    Nomiyama T; Tanaka Y; Piao L; Nagasaka K; Sakai K; Ogihara T; Nakajima K; Watada H; Kawamori R
    J Hum Genet; 2003; 48(3):138-41. PubMed ID: 12624725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylenetetrahydrofolate reductase gene polymorphism is not related to diabetic nephropathy in Japanese Type 2 diabetic patients.
    Yoshioka K; Yoshida T; Umekawa T; Kogure A; Takakura Y; Toda H; Yoshikawa T
    Diabet Med; 2004 Sep; 21(9):1051-2. PubMed ID: 15317615
    [No Abstract]   [Full Text] [Related]  

  • 9. [Polymorphic gene markers of lipid metabolism are associated with diabetic nephropathy in patients with type 1 diabetes mellitus].
    Iakunina NIu; Shestakova MV; Voron'ko OE; Vikulova OK; Sevost'ianov KV; Chugunova LA; Shamkhalova MSh; Dedov II; Nosikov VV
    Genetika; 2005 Jul; 41(7):931-7. PubMed ID: 16152798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Concept and epidemiology of diabetic nephropathy].
    Tomino Y; Tanimoto M
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():309-13. PubMed ID: 15999725
    [No Abstract]   [Full Text] [Related]  

  • 11. Association between (AC)n dinucleotide repeat polymorphism at the 5'-end of the aldose reductase gene and diabetic nephropathy: a meta-analysis.
    Xu M; Chen X; Yan L; Cheng H; Chen W
    J Mol Endocrinol; 2008 May; 40(5):243-51. PubMed ID: 18434430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insulin receptor substrate-1 and glucose transporter gene polymorphisms in noninsulin-dependent diabetes mellitus].
    Liu Z; Guan T; Chen Z
    Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):662-5. PubMed ID: 11038788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between tumour necrosis factor-alpha G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients.
    Wang Y; Ng MC; So WY; Ma R; Ko GT; Tong PC; Chan JC
    Nephrol Dial Transplant; 2005 Dec; 20(12):2733-8. PubMed ID: 16141456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haptoglobin phenotype and vascular complications in patients with diabetes.
    Levy AP; Roguin A; Hochberg I; Herer P; Marsh S; Nakhoul FM; Skorecki K
    N Engl J Med; 2000 Sep; 343(13):969-70. PubMed ID: 11012324
    [No Abstract]   [Full Text] [Related]  

  • 15. [Polymorphism of the angiotensinogen gene and genetic predisposition to diabetic nephropathy in type I diabetes mellitus].
    Chistiakov DA; Turakulov RI; Kondrat'ev IaIu; Shestakova MV; Nosikov VV; Dedov II; Debabov VG
    Mol Biol (Mosk); 1999; 33(2):211-3. PubMed ID: 10377565
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic factors in the development of diabetic nephropathy.
    Trevisan R; Viberti G
    J Lab Clin Med; 1995 Oct; 126(4):342-9. PubMed ID: 7561441
    [No Abstract]   [Full Text] [Related]  

  • 17. Polymorphism of the aldosterone synthase gene is not associated with progression of diabetic nephropathy, but associated with hypertension in type 2 diabetic patients.
    Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
    Nephrology (Carlton); 2008 Dec; 13(6):492-9. PubMed ID: 18771471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on: Lin et al. (2007) SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes: Diabetes 56: 1177-1180.
    Rudofsky G; Schlotterer A; Nawroth PP; Bierhaus A; Hamann A
    Diabetes; 2007 Aug; 56(8):e11; author reply e12-3. PubMed ID: 17660269
    [No Abstract]   [Full Text] [Related]  

  • 19. [Association of polymorphous markers Pro72Arg and C(-594)CC OF TP53 gene with diabetic polyneuropathy in patients with type 1 diabetes mellitus living in Moscow].
    Spitsina EV; Iakunina NIu; Chudakova DA; Nikitin AG; Svetlova GN; Soluianova TN; Strokov IA; Nosikov VV
    Mol Biol (Mosk); 2007; 41(6):989-93. PubMed ID: 18318116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation of a collagen IV alpha 1-chain gene polymorphism in Danish insulin-dependent diabetes mellitus (IDDM) patients: lack of association to nephropathy and proliferative retinopathy.
    Chen JW; Hansen PM; Tarnow L; Hellgren A; Deckert T; Pociot F
    Diabet Med; 1997 Feb; 14(2):143-7. PubMed ID: 9047092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.